Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1and LPA2-Reference-Cited by-同舟云学术

Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1and LPA2

Published:2008-08 Issue:8 Volume:99 Page:1603-1610
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Yamada Tadaaki,Yano Seiji,Ogino Hirokazu,Ikuta Kenji,Kakiuchi Soji,Hanibuchi Masaki,Kanematsu Takanori,Taniguchi Tetsuo,Sekido Yoshitaka,Sone Saburo

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.00848.x/fullpdf

Reference42 articles.

1. Asbestos, the mesothelial cell and malignancy: a matter of life or death;Broaddus;Am J Respir Cell Mol Biol,1997

2. Asbestos-related lung cancer and mesothelioma in Japan;Morinaga;Industrial Health,2001

3. Mineral fiber content of lungs in patients with mesothelioma seeking compensation in Quebec;Dufresne;Am J Respir Crit Care Med,1996

4. The pathogenesis of mesothelioma;Carbone;Semin Oncol,2002

5. Advances in malignant mesothelioma;Robinson;N Engl J Med,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells;Molecular Cancer Therapeutics;2023-10-06

2. The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin–lysophosphatidic acid as a new therapeutic target?;Journal of Cell Communication and Signaling;2021-03-10

3. Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2018-11

4. Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications;Journal of Materials Science: Materials in Medicine;2018-07-21

5. Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma;Cancers;2018-03-22